CN210697764U

CN210697764U - Microneedle knife for treating basal migraine

Info

Publication number: CN210697764U
Application number: CN201920919597.8U
Authority: CN
Inventors: 傅云其
Original assignee: Individual
Current assignee: Individual
Priority date: 2019-06-18
Filing date: 2019-06-18
Publication date: 2020-06-09
Anticipated expiration: 2029-06-18

Abstract

The utility model belongs to the technical field of medical appliances, and discloses a micro-needle knife for treating basal-type migraine, which is provided with a knife body; the front end of the cutter body is provided with an inclined cutting edge, and an arc-shaped baffle is welded on the outer side of the cutter body at a position 1cm away from the cutting edge; the cutter body is welded with a holding rod at the rear side of the arc-shaped baffle, and the other end of the holding rod is welded with a handle. The utility model has the knife edge of only 0.4mm, reduces the pain of the patient to the utmost extent, does not use narcotic drugs and hormones, is safe and has no side effect, the depth of the needle insertion does not exceed about 1cm, the nerves and important blood vessels can not be injured during the treatment, and the safety guarantee is provided for the clinic; the needle insertion manipulation is simple, the operation is quick, the treatment time is short, the treatment course is short, and the curative effect is instant; after operation, only slight postpain exists, the incision is not required to be protected and treated, and the measures of preventing and treating infection such as anti-inflammatory drugs and the like are not required, and the sports medicine theory is adopted, so that the medicine has the advantages of little pain, safety, no side effect and easy acceptance of patients.

Description

Microneedle knife for treating basal migraine

Technical Field

The utility model belongs to the technical field of medical appliances, especially, relate to a micropin sword of treatment basement type migraine.

Background

Currently, the closest prior art in the industry:

among primary headaches are the basilar migraine MigraineWithaura, in which the aura clearly originates in the brain stem and/or in both bilateral cerebral hemispheres, but without hypomotility. Head deviation can cause further damage in addition to the damage caused by the disease itself. People with basal migraine have higher ischemic stroke, unstable angina and transient ischemic attack than those without migraine. Especially those with migraine headaches are at higher risk of stroke and are also associated with a high risk of coronary heart disease. For a long time, medical staff in China develop a lot of basic and clinical researches for migraine, and great efforts are made to relieve the pain of diseases and reduce the burden of the diseases.

General principles of treatment: the treatment strategy for migraine headache involves two aspects: the symptomatic treatment and the preventive treatment. Symptomatic treatment aims to eliminate, inhibit or reduce pain and associated symptoms. Prophylactic treatment is used to reduce the frequency of headache episodes and to reduce the severity of headache. Whether the migraine sufferers are treated by single symptomatic treatment or both symptomatic treatment and preventive treatment needs to be analyzed specifically. Generally, if the headache has a low frequency of attack, a low pain level and a short duration, it is considered to simply select symptomatic treatment. If the headache has high attack frequency, high pain degree, long duration and obvious influence on work, study and life, proper preventive treatment is given while symptomatic treatment is given. In summary, both the effect of pain and the effect of side effects of drugs on patients are considered, sometimes with reference to individual opinions of patients. Both symptomatic and prophylactic treatment involve two aspects, namely pharmaceutical and non-pharmaceutical intervention. Non-drug intervention, emphasizing self-help for patients. The patients are ordered to record the antecedent symptoms, the attack and duration of headache and the accompanying symptoms in detail, and find out the factors for inducing and relieving headache, and avoid the factors as much as possible. The medicine is used for symptomatic treatment: the symptomatic treatment of migraine can be achieved by non-specific drug therapy, including simple analgesics, non-simple disappearing drugs and anesthetics. For mild and moderate headache, simple analgesics and non-simple anti-inflammatory drugs can often relieve the onset of headache. The traditional Chinese medicine treatment comprises the following steps: the headache is classified into internal injury headache according to the syndrome differentiation principle of the traditional Chinese medicine, and also can be treated according to the syndrome differentiation principle of channels and collaterals; acupuncture, needle knife or local massage therapy can alleviate and relieve some symptoms of basal migraine. However, the existing treatment means generally have the problems of long treatment course and slow curative effect, and the pain of patients is increased by the existing needle knife treatment, so that nerves and important blood vessels are easily injured, and the safety factor is low.

In summary, the problems of the prior art are as follows:

the existing treatment means has the problems of long treatment course and slow curative effect, and the pain of a patient is increased by the existing needle knife treatment, the nerve and important blood vessels are easily injured, and the safety factor is low.

SUMMERY OF THE UTILITY MODEL

To solve the problems existing in the prior art, the utility model provides a microneedle knife for treating basal migraine.

The utility model discloses a realize like this, a micropin sword of treatment basement type migraine is provided with:

a cutter body;

the front end of the cutter body is provided with an inclined cutting edge, and an arc-shaped baffle is welded on the outer side of the cutter body at a position 1cm away from the cutting edge;

the cutter body is welded with a holding rod at the rear side of the arc-shaped baffle, and the other end of the holding rod is welded with a pinching handle.

Further, the blade width is 0.4 mm.

Furthermore, the diameter of the holding rod is larger than that of the cutter body, and anti-skid grains are formed in the outer side of the holding rod.

Furthermore, anti-skidding cross grains are arranged on the surfaces of the two sides of the handle.

To sum up, the utility model discloses an advantage and positive effect do:

1. the knife edge is only 0.4mm, and the pain of the patient is relieved to the maximum extent. 2. It is safe and has no side effect. 3. The depth of the needle insertion is not more than about 1cm, the nerve and important blood vessels are not injured during treatment, and the safety guarantee is provided for clinic. 4. The needle insertion is simple, and there is no other auxiliary method for lifting, inserting and cutting. 5. The operation is fast, the treatment time is short, and the treatment course is short. 6. The curative effect is immediate. 7. Cutting the part by a knife method: the deep and superficial fascia, muscle joints, superficial muscle attachment points, and cutaneous nerve entrapment sites. 8. After the ultramicro needle knife operation, only slight postoperatively pain exists, the knife edge does not need to be protected and treated, and the bath can be taken in the same day. The measures of anti-inflammatory drugs and the like for preventing and treating infection are not needed. The utility model adopts the theory of sports medicine, has little pain, safety and no side effect, and is a therapy which is easy to be accepted by patients.

Drawings

Fig. 1 is a schematic structural view of a microneedle knife for treating basal migraine according to an embodiment of the present invention;

in the figure: 1. a cutter body; 2. a blade; 3. an arc-shaped baffle plate; 4. a holding rod; 5. a handle.

Detailed Description

In order to further understand the contents, features and effects of the present invention, the following embodiments are illustrated and described in detail with reference to the accompanying drawings.

As shown in fig. 1, a microneedle knife for treating basal migraine according to an embodiment of the present invention includes: the knife comprises a knife body 1, a knife edge 2, an arc-shaped baffle 3, a holding rod 4 and a handle 5.

The front end of the cutter body 1 is provided with an inclined cutting edge 2, and an arc-shaped baffle 3 is welded on the outer side of the cutter body 1 at a position 1cm away from the cutting edge; the cutter body 1 is welded with a holding rod 4 at the rear side of the arc-shaped baffle 3, and the other end of the holding rod 4 is welded with a handle 5.

Preferably, the width of the blade 3 is 0.4 mm.

Preferably, the diameter of the holding rod 4 is larger than that of the cutter body 2, and the outer side of the holding rod 4 is provided with anti-skid grains.

Preferably, the two side surfaces of the handle 5 are provided with anti-skid transverse striations.

The utility model discloses a theory of operation is:

point selection (site selection for application): the patient has migraine at the lateral sub-occipital muscle group, namely the position of the back occipital part close to the skull bone surface and the position of the back ear close to the mastoid.

The treatment operation method comprises the following steps:

A. taking the patient in prone position or prone position, one side or two sides;

B. the physician touches the patient's occipital muscle group with the thumb or index finger of the left (or right) hand with the free hand on the migraine side of the patient, and touches one or more of the tiny cord-like nodes at the deep and superficial fascia, tendons and tendons, superficial muscle attachment points, and cutaneous nerve entrapment.

C. Enabling the assistant to disinfect the local part of the assistant by a Begal iodophor disinfection cotton ball and a 75% alcohol cotton ball in a conventional way;

D. an operator carries sterile latex gloves with two hands, holds the handle 5 of the micro-needle knife with the thumb and the two fingers of the right hand, the blade 3 is in the direction of the longitudinal axis, touches and forcibly presses the cord-shaped nodule with the thumb (or the index finger) of the left hand, cuts the blade 3 one by one in the direction parallel to the cord-shaped nodule, the depth of needle insertion does not exceed about lcm, and the cutting is carried out without any other auxiliary methods;

E. during operation, the cutting is respectively carried out for 1-3 times according to the size of the cord-shaped nodule, and the "chuck" sound can be heard during operation;

F. if the local part has hemorrhage, pressing with sterile dry cotton ball, and sterilizing with 75% ethanol.

The treatment course comprises 1 treatment every other day, and seven treatment courses are taken as one treatment course.

The above description is only for the preferred embodiment of the present invention, and is not intended to limit the present invention in any way, and all the modifications and equivalents of the technical spirit of the present invention to any simple modifications of the above embodiments are within the scope of the technical solution of the present invention.

Claims

1. A microneedle blade for treating basal-type migraine is characterized by being provided with:

a cutter body;

2. The microneedle knife of claim 1, wherein said blade edge has a width of 0.4 mm.

3. The microneedle knife of claim 1, wherein the diameter of the handle is larger than the diameter of the knife body, and the outer side of the handle is provided with anti-slip threads.

4. The microneedle knife of claim 1, wherein the handle has non-slip cross-striations on both side surfaces.